is a biomedical research and development corporation based in Vancouver, Canada
on the treatment of structural heart disease, specifically mitral valve disease causing mitral regurgitation
is the percutaneous treatment of mitral regurgitation with novel medical devices that respect the proven principles of surgical mitral valve repair.
+1 778 776 8565
Vesalius Cardiovascular Inc., 2016